ClassID:

96740

C07K7/08 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Sub-classes:
Recent Application in this class:
#1
20260139244
2026-05-21

REAGENTS AND METHODS FOR CELL IDENTIFICATION AND CHARACTERIZATION

#2
20260139022
2026-05-21

COMPOSITIONS INCLUDING TUMOR-BINDING GMCSF FUSION PROTEINS AND METHODS OF USING THE SAME TO TREAT SOLID TUMORS

#3
20260139005
2026-05-21

SYNTHETIC ANTIMICROBIAL PEPTIDES

#4
20260134941
2026-05-14

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

#5
20260125425
2026-05-07

Carrier Peptide Fragment and Use Thereof

#6
20260124312
2026-05-07

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2

#7
20260116954
2026-04-30

CHIMERIC PROTEIN COMPRISING AN ANTI-INFLUENZA VIRUS ANTIBODY MOIETY AND A MUCOADHESIVE PEPTIDE FRAGMENT FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

#8
20260116933
2026-04-30

INHIBITORS OF NFAT AND NFKB SIGNALING FOR IMPROVING IMMUNE CELL FUNCTION

#9
20260116919
2026-04-30

SELF-ASSEMBLING PEPTIDE COMPOSITIONS

#10
20260116918
2026-04-30

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

#11
20260103490
2026-04-16

EPITOPE TAGS RECOGNIZED BY SPECIFIC BINDERS

#12
20260103489
2026-04-16

EPITOPE TAGS RECOGNIZED BY SPECIFIC BINDERS

#13
20260103488
2026-04-16

ACTIVATING AGENTS

#14
20260098059
2026-04-09

COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS

#15
20260092084
2026-04-02

PEPTIDE AND ASSEMBLY OR COMPOSITION CONTAINING SAID PEPTIDE

#16
20260092082
2026-04-02

ANTIMICROBIAL PEPTIDE HALYMORIN VARIANTS AND METHODS OF USING THE SAME

#17
20260091159
2026-04-02

SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE

#18
20260091120
2026-04-02

CELL-PENETRATING PEPTIDES

#19
20260085093
2026-03-26

INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF

#20
20260085092
2026-03-26

MELANOCORTIN RECEPTOR LIGANDS

#21
20260083852
2026-03-26

PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR

#22
20260078147
2026-03-19

INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF

#23
20260078146
2026-03-19

EPHA2 TARGETING AGENTS AND USES THEREOF

#24
20260077071
2026-03-19

Targeted Delivery of Theranostic Agents

#25
20260071197
2026-03-12

ENGINEERED CASCADE COMPONENTS AND CASCADE COMPLEXES

#26
20260070955
2026-03-12

OFF-THE-SHELF CANCER VACCINES

#27
20260070946
2026-03-12

TYR PEPTIDE COMPOSITIONS AND METHODS FOR USE

#28
20260069525
2026-03-12

ANTIMICROBIAL PEPTIDE FOR MAINTAINING HEALTH OF SCALP MICROBIOME AND METHOD FOR PREVENTION OR TREATMENT OF SCALP DISEASE USING THE SAME

#29
20260062448
2026-03-05

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF

#30
20260062445
2026-03-05

PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES

#31
20260062444
2026-03-05

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS

#32
20260061086
2026-03-05

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

#33
20260061049
2026-03-05

SELF-ASSEMBLING PEPTIDE SCAFFOLD

#34
20260055140
2026-02-26

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS

#35
20260055139
2026-02-26

METHOD OF TREATMENT OF NEUTROPHIL-DRIVEN INFLAMMATORY PATHOLOGIES

#36
20260055138
2026-02-26

CARRIER PEPTIDE FRAGMENT AND USE THEREOF

#37
20260049104
2026-02-19

PEPTIDES WITH ANTIMICROBIAL PROPERTIES

#38
20260047574
2026-02-19

BIOACTIVE PEPTIDES FOR CONTROLLING INSECTS

#39
20260042800
2026-02-12

ANTIMICROBIAL PEPTIDOMIMETICS

#40
20260035410
2026-02-05

THERAPEUTIC PEPTIDES AND METHODS OF PEPTIDE DESIGN

#41
20260035409
2026-02-05

BRINP2-DERIVED PEPTIDE COMPOSITIONS FOR TREATING OBESITY AND WEIGHT MANAGEMENT

#42
20260028373
2026-01-29

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

#43
20260021213
2026-01-22

METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT

#44
20260014263
2026-01-15

PEPTIDE OLIGONUCLEOTIDE CONJUGATES

#45
20260008823
2026-01-08

CRM197 PROTEIN EXPRESSION METHOD

#46
20260008814
2026-01-08

DEVELOPMENT OF PEPTIDES WITH ANTI-CANCER AND ANTIMICROBIAL PROPERTIES

#47
20260001924
2026-01-01

NEMO COILED COIL MIMICS AND METHODS OF USING SAME

#48
20260001913
2026-01-01

PEPTIDE EXHIBITING ANTIBACTERIAL AND ANTI-INFLAMMATORY ACTIVITIES AND METHOD FOR TREATING MEDICAL CONDITION WITH THE SAME

#49
20260001912
2026-01-01

IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF

#50
20260000773
2026-01-01

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2

#51
20250388623
2025-12-25

PEPTIDE INHIBITOR AND USE THEREOF

#52
20250387498
2025-12-25

CELL-PENETRATING PEPTIDES

#53
20250382332
2025-12-18

NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY

#54
20250382331
2025-12-18

Carrier Peptide Fragment and Use Thereof

#55
20250382330
2025-12-18

IMMUNOLOGICALLY ACTIVE POLYPEPTIDE

#56
20250381293
2025-12-18

PEPTIDES AND MAGNETIC PARTICLE-PEPTIDE CONJUGATES FOR PREVENTION OR TREATMENT OF GLAUCOMA

#57
20250381242
2025-12-18

ANTIMICROBIAL PEPTIDES AGAINST CITRUS GREENING

#58
20250368694
2025-12-04

SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES

#59
20250368685
2025-12-04

DEFENSIN FRAGMENTS FOR USE IN THERAPY OR PROPHYLAXIS

#60
20250368684
2025-12-04

NEW EGFRVIII-BINDING PEPTIDES, CONJUGATES AND USES THEREOF

#61
20250368683
2025-12-04

METHOD FOR TREATING OR PREVENTING BRONCHIAL ALLERGIC DISEASES WITH PEPTIDE COMPOSITION

#62
20250361274
2025-11-27

PEPTIDE AND PEPTIDE-CONTAINING AGENT

#63
20250346664
2025-11-13

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#64
20250346632
2025-11-13

SERPIN PEPTIDES AND METHODS OF USING THE SAME

#65
20250346631
2025-11-13

PEPTIDE COMPOSITIONS AND METHODS OF USE

#66
20250346630
2025-11-13

Engineering Peptides Using Peptide Epitope Linker Evolution

#67
20250346629
2025-11-13

USE OF D-ENANTIOMERIC PEPTIDE LIGANDS OF MONOMERIC ALPHA-SYNUCLEIN FOR THE THERAPY OF VARIOUS SYNUCLEINOPATHIES

#68
20250340593
2025-11-06

METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDER

#69
20250339503
2025-11-06

PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA (AML) AND OTHER HEMATOLOGICAL NEOPLASMS

#70
20250339470
2025-11-06

METHODS AND COMPOSITIONS FOR MATURING CARDIOMYOCYTES

#71
20250333666
2025-10-30

LIQUID DETERGENT AND UNIT DOSE DETERGENT COMPOSITIONS AND METHODS OF USING THE SAME

#72
20250333488
2025-10-30

PEPTIDE-HINGE-FREE FLEXIBLE ANTIBODY-LIKE MOLECULE

#73
20250333472
2025-10-30

Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto

#74
20250333443
2025-10-30

DPEP-1 BINDING AGENTS AND METHODS OF USE

#75
20250333441
2025-10-30

POLYPEPTIDE INHIBITORS AND USES THEREOF

#76
20250332340
2025-10-30

COMPOSITIONS AND METHODS FOR CNS DISEASES

#77
20250332275
2025-10-30

Branched Polypeptide Carrier for Efficient Nucleic Acid Delivery and Its Variants

#78
20250332264
2025-10-30

GhR-BINDING PEPTIDE AND COMPOSITION COMPRISING SAME

#79
20250326799
2025-10-23

AGENTS INDUCING VASCULARISATION

#80
20250326797
2025-10-23

PROTEIN-PROTEIN INTERACTION MODULATORS AND METHODS FOR DESIGN THEREOF

#81
20250326796
2025-10-23

PEPTIDE ANALOG WITH ANTI-INFLAMMATORY ACTIVITY AND ITS PREPARATION METHOD AND APPLICATION

#82
20250326795
2025-10-23

USE OF D-ENANTIOMERIC PEPTIDE LIGANDS OF MONOMERIC TAU FOR THE THERAPY OF VARIOUS TAUOPATHIES

#83
20250326794
2025-10-23

ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF

#84
20250320250
2025-10-16

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISCERAL PAIN

#85
20250320248
2025-10-16

MENAQUINONE-BINDING COMPOUNDS AND METHODS OF USE THEREOF

#86
20250312260
2025-10-09

COMPOSITION FOR IMPROVING HAIR HEALTH

#87
20250311587
2025-10-02

VASCULAR EMBOLIC SYSTEM

#88
20250305981
2025-10-02

SWITCHING PEPTIDE AND IMMUNOASSAY USING SAME

#89
20250304624
2025-10-02

CONJUGATED HEPCIDIN MIMETICS

#90
20250304623
2025-10-02

PEPTIDES FOR INTRACELLULAR DELIVERY

#91
20250304622
2025-10-02

SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE

#92
20250304621
2025-10-02

POLYPEPTIDE FOR SPECIFICALLY BLOCKING BINDING OF ACVR1C TO GREM1 AND USE THEREOF

#93
20250304620
2025-10-02

ANTIMICROBIAL PEPTIDE AND APPLICATION THEREOF

#94
20250304619
2025-10-02

INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES

#95
20250303003
2025-10-02

METHODS OF ON DEMAND IN VIVO PHOTOTAGGING

#96
20250302986
2025-10-02

NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME

#97
20250302963
2025-10-02

PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES

#98
20250302910
2025-10-02

DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF

#99
20250297290
2025-09-25

SEQUENCE FOR PROTEIN DECAY

#100
20250296957
2025-09-25

PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY

#101
20250296956
2025-09-25

POLYPEPTIDE, PREPARATION METHOD, AND USE THEREOF

#102
20250295796
2025-09-25

CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY

#103
20250295616
2025-09-25

A SYSTEM AND METHOD FOR COMPARTMENTALIZED INGREDIENTS FOR A LIQUID PHARMACEUTICAL FORMULATION

#104
20250295570
2025-09-25

PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF

#105
20250289850
2025-09-18

NOVEL ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF

#106
20250289849
2025-09-18

PEPTIDE TO TREAT ALPHA-SYNUCLEIN AMYLOID BASED DISORDERS

#107
20250287937
2025-09-18

COMPOSITIONS AND METHODS FOR REDUCING ICE CRYSTAL FORMATION

#108
20250282823
2025-09-11

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#109
20250282822
2025-09-11

SYNTHETIC ANTIMICROBIAL PEPTIDES

#110
20250281629
2025-09-11

COMPOSITIONS AND METHODS FOR ANTI-PHOSPHOCHOLINE ACTIVE IMMUNOTHERAPY

#111
20250281572
2025-09-11

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS

#112
20250277001
2025-09-04

PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS

#113
20250276999
2025-09-04

PEPTIDES FOR PROMOTING HAIR FOLLICLE NEOGENESIS, AND PREVENTION/MITIGATION OF UNTOWARD EFFECTS OF RADIATION TREATMENT

#114
20250276073
2025-09-04

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

#115
20250270259
2025-08-28

ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#116
20250270256
2025-08-28

NOVEL ANTIMICROBIAL PEPTIDE WITH EXCELLENT MICROBIAL CYTOPLASM ELUTION EFFECT

#117
20250270254
2025-08-28

PROBES AND KITS FOR THE EARLY DIAGNOSIS OF DIFUSE LARGE B-CELL LYMPHOMA

#118
20250269069
2025-08-28

METHODS OF USING SELECTIVE DELIVERY MOLECULES

#119
20250269046
2025-08-28

CELLULAR UPTAKE OF LARGE BIOMOLECULES ENABLED BY CELL-SURFACE-REACTIVE CELL-PENETRATING PEPTIDE ADDITIVES

#120
20250263439
2025-08-21

HETERODIMERIC PEPTIDE REAGENTS AND METHODS

#121
20250263438
2025-08-21

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#122
20250263437
2025-08-21

POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF

#123
20250263436
2025-08-21

BROAD-SPECTRUM ANTIVIRAL DRUG FOR ENTEROVIRUS, AND APPLICATION

#124
20250262333
2025-08-21

Construct for Transferring Foreign Substance, and Use Thereof

#125
20250262139
2025-08-21

POLYPEPTIDES AND METHODS FOR IMPROVING SKIN CONDITIONS

#126
20250257342
2025-08-14

PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES

#127
20250255975
2025-08-14

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP

#128
20250250298
2025-08-07

ONCOLYTIC PEPTIDE AND USE THEREOF

#129
20250249110
2025-08-07

ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF

#130
20250243243
2025-07-31

DISRUPTION OF SONIC HEDGEHOG-SURF4 INTERACTION FOR CANCER TREATMENT

#131
20250230191
2025-07-17

PEPTIDE LIGANDS FOR BINDING TO MT1-MMP

#132
20250230190
2025-07-17

COMPOSITION FOR ENHANCING ACTIVITY OF NATURAL KILLER CELLS

#133
20250228778
2025-07-17

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#134
20250222119
2025-07-10

ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY

#135
20250215053
2025-07-03

LYSINE RICH CELL-PENETRATING PEPTIDES

#136
20250215051
2025-07-03

Transmembrane Allosteric Short Peptides Modulating Human Mu-Opioid Receptor for Analgesic Effects and Covalent Steroid Modifications of Transmembrane Allosteric Peptides for Enhanced Mu-Opioid Receptor Interaction in Chronic Pain Therapies

#137
20250213643
2025-07-03

COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION

#138
20250213452
2025-07-03

BIFUNCTIONAL PEPTIDES FOR BIOMIMETIC RECONSTRUCTION OF SILVER DIAMINE FLUORIDE TREATED DENTAL TISSUES

#139
20250205302
2025-06-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODAMAGE

#140
20250204535
2025-06-26

Rodenticide

#141
20250197453
2025-06-19

COMPOSITION COMPRISING TAT PEPTIDE VARIANT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING METABOLIC DISEASES

#142
20250197447
2025-06-19

PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF

#143
20250188172
2025-06-12

COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME

#144
20250179487
2025-06-05

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

#145
20250179130
2025-06-05

METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS

#146
20250179125
2025-06-05

Alpha-sheet Polypeptides and Their Use

#147
20250177474
2025-06-05

PROTEIN INTERFACES

#148
20250177423
2025-06-05

PHOTORESPONSIVE PEPTIDE DELIVERY SYSTEM AND METHOD OF USING THE SAME

#149
20250172552
2025-05-29

MONOCLONAL ANTIBODIES FOR DETECTING KAWASAKI DISEASE ANTIGENS

#150
20250171497
2025-05-29

ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME

#151
20250170209
2025-05-29

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

#152
20250163115
2025-05-22

BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss

#153
20250163113
2025-05-22

PEPTIDES TARGETING THE INTERACTION BETWEEN KINDLIN-1 AND Beta-INTEGRIN

#154
20250163103
2025-05-22

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

#155
20250154199
2025-05-15

PEPTIDES FOR TREATING PAIN OR REDUCING PAIN SENSITIVITY

#156
20250154198
2025-05-15

PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR

#157
20250152656
2025-05-15

INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS

#158
20250144221
2025-05-08

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

#159
20250130235
2025-04-24

PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#160
20250129124
2025-04-24

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

#161
20250129123
2025-04-24

BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION

#162
20250129122
2025-04-24

PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE

#163
20250129121
2025-04-24

POLYPEPTIDE, PRODUCT INCLUDING POLYPEPTIDE FOR INHIBITING FUSOBACTERIUM NUCLEATUM, OR DRUG FOR PREVENTING COLORECTAL CANCER

#164
20250129118
2025-04-24

MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE

#165
20250127842
2025-04-24

IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES

#166
20250127136
2025-04-24

NOVEL METHOD FOR PROMOTING NODULATION IN PLANTS

#167
20250123280
2025-04-17

LABEL-FREE DETECTION OF PROTEASE ACTIVITY

#168
20250115642
2025-04-10

PEPTIDE HAVING ANTIBACTERIAL, ANTI-INFLAMMATORY OR TISSUE REGENERATION ABILITY AND USE THEREOF

#169
20250115641
2025-04-10

STAPLED PEPTIDES AS PYRIN-DOMAIN TARGETED NLRP3 INFLAMMASOME INHIBITORS

#170
20250115640
2025-04-10

NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF

#171
20250114429
2025-04-10

VISTA ANTAGONIST AND METHODS OF USE

#172
20250109197
2025-04-03

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#173
20250109169
2025-04-03

PEPTIDE USEFUL FOR THE TRANSPORT OF MOLECULES THROUGH CELL BARRIERS

#174
20250109168
2025-04-03

POLYPEPTIDE AND USE THEREOF IN REGULATING BLOOD GLUCOSE LEVEL AND/OR REDUCING FAT

#175
20250101063
2025-03-27

POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS

#176
20250093352
2025-03-20

USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM

#177
20250092120
2025-03-20

ANTICANCER PEPTIDE AND USE IN TREATING CANCER

#178
20250092103
2025-03-20

Peptides for the Treatment of Retinitis Pigmentosa

#179
20250092092
2025-03-20

ANTIBODY/DRUG CONJUGATES AND METHODS OF USE

#180
20250090651
2025-03-20

RESPIRATORY SYNCYTIAL VIRUS F PROTEINS AND NANOSTRUCTURES AND USES THEREOF

#181
20250084368
2025-03-13

CELL CULTURE SCAFFOLD, AND PREPARATION METHOD THEREOF

#182
20250084126
2025-03-13

PEPTIDE AND COMPOSITION

#183
20250075229
2025-03-06

Genetically Reprogrammed Extracellular Matrix

#184
20250074947
2025-03-06

ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME

#185
20250074946
2025-03-06

USE OF SE-DR AFFINITY PEPTIDE IN PREPARING DRUG FOR TREATING RHEUMATIC DISEASE

#186
20250074943
2025-03-06

DLL3 BINDING PEPTIDES AND USES THEREOF

#187
20250073355
2025-03-06

CD44-BINDING PEPTIDE REAGENTS AND METHODS

#188
20250073337
2025-03-06

NOVEL SKIN-PERMEABLE PEPTIDE, COMPOSITION INCLUDING THE SAME FOR SKIN AND MUCOUS MEMBRANE, AND USE THEREOF

#189
20250066422
2025-02-27

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

#190
20250066421
2025-02-27

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#191
20250066420
2025-02-27

PD-L1 INHIBITORY PEPTIDE FOR CANCER IMMUNOTHERAPY

#192
20250066418
2025-02-27

CYSTEINE PEPTIDE-ENABLED ANTIBODIES

#193
20250060359
2025-02-20

FUSION PROTEINS AND METHODS FOR MONITORING FIBRONECTIN MATRIX ASSEMBLY

#194
20250059499
2025-02-20

CELL-SURFACE ENGINEERING COMPOSITIONS AND METHODS FOR THE PREVENTION OF IMMUNE REJECTION

#195
20250059263
2025-02-20

ERYTHROCYTE-BINDING THERAPEUTICS

#196
20250059234
2025-02-20

VARIABLE LYMPHOCYTE RECEPTORS THAT TARGET THE BRAIN EXTRACELLULAR MATRIX AND METHODS OF USE

#197
20250057751
2025-02-20

PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF

#198
20250051857
2025-02-13

PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

#199
20250051392
2025-02-13

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#200
20250051391
2025-02-13

PEPTIDE INHIBITORS AND METHODS FOR INHIBITING PROTEIN AGGREGATION IN NEURONS AND NEURODEGENERATIVE DISEASES

#201
20250049881
2025-02-13

FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE

#202
20250042947
2025-02-06

PEPTIDE LIBRARY AND USE THEREOF

#203
20250042946
2025-02-06

Biological Production of Histidine-Rich Peptides

#204
20250042940
2025-02-06

14-3-3 TARGETING PEPTIDES FOR CANCER TREATMENT

#205
20250041195
2025-02-06

COLLAGEN TYPE III COMPOSITION PREPARED FROM FIBROBLAST EXTRACELLULAR MATRIX

#206
20250034235
2025-01-30

COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

#207
20250034208
2025-01-30

PEPTIDES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

#208
20250034207
2025-01-30

PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS

#209
20250026789
2025-01-23

PEPTIDE HAVING INHIBITORY ACTIVITY AGAINST AMYLOID PRECURSOR PROTEIN AND USE THEREOF

#210
20250026788
2025-01-23

PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION

#211
20250022022
2025-01-16

ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION

#212
20250019403
2025-01-16

CLEAVABLE LINKER COMPOSITIONS AND METHODS

#213
20250019402
2025-01-16

PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY

#214
20250019401
2025-01-16

ANTIMICROBIAL PEPTIDE BOLESPLEENIN OF BOLEOPHTHALMUS PECTINIROSTRIS AND APPLICATION THEREOF

#215
20250011794
2025-01-09

TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME

#216
20250011364
2025-01-09

TUMOR TISSUE-PENETRATING PEPTIDE, SPECIFICALLY BINDING TO NEUROPILIN 1, FOR DRUG DELIVERY TO TUMOR, AND USE THEREOF

#217
20250009931
2025-01-09

FILMS FORMED FROM SELF-ASSEMBLING PEPTIDE HYDROGELS

#218
20250009909
2025-01-09

METHODS AND COMPOSITIONS FOR VISUALIZING A URETER IN A SURGICAL PROCEDURE

#219
20250002536
2025-01-02

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#220
20250002535
2025-01-02

PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND ITS USE

#221
20250002534
2025-01-02

PEPTIDE COMPOSITIONS CAPABLE OF BINDING LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF

#222
20250002532
2025-01-02

A NOVEL PEPTIDE AND THE USE THEREOF

#223
20250000959
2025-01-02

NUCLEIC ACID MOLECULES, FUSION PROTEINS, AND MRNA VACCINES WITH ENHANCED ANTIGEN PRESENTATION BY RECRUITING LIGANDS

#224
20240425843
2024-12-26

MESOPOROUS SILICA BINDING PEPTIDES AND METHODS OF ENZYME IMMOBILIZATION USING THE SAME

#225
20240425584
2024-12-26

MECHANICALLY INTERLOCKING COMPLEXES

#226
20240424134
2024-12-26

PEPTIDE HAVING INDEPENDENTLY STABILIZED HYDROPHOBIC ALPHA HELIX, PEPTIDE COMPLEX COMPRISING SAME AND USES THEREOF

#227
20240417428
2024-12-19

POLYPEPTIDE FOR INHIBITING TRPM8 AND USE THEREOF

#228
20240409584
2024-12-12

PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF

#229
20240409583
2024-12-12

ANTAGONIST FUSION POLYPEPTIDES

#230
20240408166
2024-12-12

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

#231
20240407993
2024-12-12

PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF

#232
20240400696
2024-12-05

COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME

#233
20240400616
2024-12-05

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#234
20240398964
2024-12-05

PEPTIDE FOR PENETRATING BLOOD-BRAIN BARRIER AND USE THEREOF

#235
20240392392
2024-11-28

ENGINEERING AAV

#236
20240392319
2024-11-28

TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME

#237
20240391957
2024-11-28

BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES

#238
20240391956
2024-11-28

STAPLED PEPTIDES AND METHODS THEREOF

#239
20240385195
2024-11-21

PEPTIDE FOR DETECTING CA125 AND USE THEREOF

#240
20240383953
2024-11-21

NOVEL NANOMATERIALS FROM NANOG PRION-LIKE REPEATS

#241
20240376357
2024-11-14

Substrate-specific adhesive peptides

#242
20240376153
2024-11-14

CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE

#243
20240376152
2024-11-14

PEPTIDES THAT BIND TO TEXTILES

#244
20240376151
2024-11-14

STAPLED PEPTIDES AND METHODS THEREOF

#245
20240376150
2024-11-14

Biological active peptide for improving enzyme activity of ACE2 and application thereof

#246
20240374585
2024-11-14

EPITHELIAL SODIUM CHANNEL (ENAC) INHIBITOR CONJUGATES AND METHODS FOR USE THEREOF

#247
20240368223
2024-11-07

SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDE

#248
20240368222
2024-11-07

PEPTIDE HAVING BLOOD COAGULATION ACTIVITY, AND USE THEREOF

#249
20240368220
2024-11-07

IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF

#250
20240366836
2024-11-07

STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION

#251
20240360177
2024-10-31

PEPTIDES WITH ANTIMICROBIAL ACTIVITIES

#252
20240360176
2024-10-31

METHODS FOR TREATMENT AND DIAGNOSIS OF NON-ALCOHOLIC STEATOHEPATITIS AND/OR HEPATOCELLULAR CARCINOMA

#253
20240360175
2024-10-31

PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS

#254
20240358846
2024-10-31

Nanoparticles and Peptides for the Delivery of Cargos to Muscle Cells

#255
20240352151
2024-10-24

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH

#256
20240352093
2024-10-24

PEPTIDE AND GELATIN HYBRID HYDROGELS AS ECONOMICAL ALTERNATIVES TO COMMON BASEMENT-MEMBRANE MATRICES

#257
20240352072
2024-10-24

NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS

#258
20240350602
2024-10-24

NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS

#259
20240343765
2024-10-17

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#260
20240336659
2024-10-10

CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME

#261
20240336656
2024-10-10

HETEROTANDEM BICYCLIC PEPTIDE COMPLEX

#262
20240336655
2024-10-10

AMPHIPHILIC PEPTIDES FOR NUCLEIC ACID AND PROTEIN DELIVERY

#263
20240336654
2024-10-10

ANTIMICROBIAL PEPTIDOMIMETICS

#264
20240336653
2024-10-10

PEPTIDE COMPOUND TARGETING ELASTIN-DERIVED PEPTIDES AND USE THEREOF

#265
20240327462
2024-10-03

SHORT PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF IN TREATING NEUROLOGICAL DISEASES

#266
20240327461
2024-10-03

APELIN POLYPEPTIDES

#267
20240327460
2024-10-03

NORA INHIBITORS AND METHODS OF USE

#268
20240327459
2024-10-03

PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES

#269
20240318143
2024-09-26

POST-PROCESSING OF BIOLOGICAL SCAFFOLDS

#270
20240317806
2024-09-26

TOPICAL PEPTIDE FORMULATION FOR THE TREATMENT OF SEXUAL DYSFUNCTION

#271
20240317805
2024-09-26

WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE

#272
20240316101
2024-09-26

REGULATORY T CELL EPITOPES

#273
20240309059
2024-09-19

PEPTIDE HAVING ANTI-VIRAL ACTIVITY, ANTI-VIRAL AGENT COMPRISING SAID PEPTIDE, AND METHOD FOR PRODUCING SAID ANTI-VIRAL AGENT

#274
20240309047
2024-09-19

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

#275
20240309046
2024-09-19

COMPSTATIN ANALOGUES AND THEIR MEDICAL USES

#276
20240309045
2024-09-19

NLRP3 INFLAMMASOME INHIBITORY PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASES

#277
20240301014
2024-09-12

MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION

#278
20240301003
2024-09-12

PLASMIN-RESISTANT PEPTIDES FOR IMPROVED THERAPEUTIC INDEX

#279
20240301002
2024-09-12

NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER

#280
20240299515
2024-09-12

MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF

#281
20240295557
2024-09-05

METHODS FOR DETECTING PEPTIDE/MHC/TCR BINDING

#282
20240294574
2024-09-05

STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN

#283
20240294573
2024-09-05

CONSTRAINED PEPTIDES

#284
20240294572
2024-09-05

Antimicrobial Peptides

#285
20240294571
2024-09-05

ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS

#286
20240287491
2024-08-29

PROCASPASE-CLEAVING PROTEASES AND USES THEREOF

#287
20240287171
2024-08-29

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#288
20240287137
2024-08-29

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#289
20240287136
2024-08-29

PHARMACEUTICAL COMPOSITION AND THE USE THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES

#290
20240287135
2024-08-29

ANTIMICROBIAL PEPTIDE OR PEPTIDE DERIVATIVE, SUBSTITUTE, AND COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF COMPOSITION

#291
20240287134
2024-08-29

PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTS

#292
20240287132
2024-08-29

PEPTIDE, COMPOSITION, AND GHRELIN SECRETION PROMOTING AGENT

#293
20240285783
2024-08-29

DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS

#294
20240285738
2024-08-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS

#295
20240285725
2024-08-29

DOSING REGIMENS

#296
20240279330
2024-08-22

ERYTHROCYTE-BINDING THERAPEUTICS

#297
20240279280
2024-08-22

COMPOUNDS FOR USE AS APELIN RECEPTOR ANTAGONISTS

#298
20240277861
2024-08-22

ANTI-HEPATITIS B VIRUS AGENT TARGETING HOST FACTOR LIPG

#299
20240269228
2024-08-15

SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM

#300
20240269225
2024-08-15

Dry powder formulation of caveolin-1 peptides and methods of use thereof